Last reviewed · How we verify

Treatment of adult smokers to help them stop smoking — Treatment Landscape & Competitive Intelligence

Treatment of adult smokers to help them stop smoking (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Treatment of adult smokers to help them stop smoking, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Chantix Varenicline Tartrate Pfizer Inc. Nicotinic receptor partial agonist α4β2 neuronal nicotinic acetylcholine receptors

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer Inc. · 1 drug in Treatment of adult smokers to help them stop smoking

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Treatment of adult smokers to help them stop smoking:

Cite this brief

Drug Landscape (2026). Treatment of adult smokers to help them stop smoking — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/treatment-of-adult-smokers-to-help-them-stop-smoking. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing